Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | 1₹27,272Accepted-AOC | ₹27,272 Quoted ₹928.25 | 1 | Accepted-AOC Awarded Value depends on requirment throughout the contract period |
| 2 | 1₹27,272Accepted-AOC | ₹27,272 Quoted ₹2.4 L | 1 | Accepted-AOC Awarded Value depends on requirment throughout the contract period |
| 3 | 1₹27,272Accepted-AOC | ₹27,272 Quoted ₹2.5 L | 1 | Accepted-AOC Awarded Value depends on requirment throughout the contract period |
| 4 | 1₹27,272Accepted-AOC | ₹27,272 Quoted ₹16,587.96 | 1 | Accepted-AOC Awarded Value depends on requirment throughout the contract period |
| 5 | 1₹27,272Accepted-AOC 0 BUDSHAH CHOWK 1ST FLOOR TAJ HOTEL AUQAF BUILDING BUDSHAH CHOWK SRINAGAR JAMMU KASHMIR 190001 | SRINAGAR | JAMMU AND KASHMIR | 190001 | ₹27,272 Quoted ₹1.2 L | 1 | Accepted-AOC Awarded Value depends on requirment throughout the contract period |
| Sl No | Description | Qty | Unit | ARCO PHARMACEUTICAL DISTRIBUTORS L1 | S B S TRADERS L8 | Laboratory sales Corporation L6 | RESHI ASSOCIATES L3 | Medax Medical Systems L7 | M Z SCIENTIFIC TRADERS L9 | Lifeline Distribution L4 | ISRAR ENTERPRISES L11 | MUDASIR SCIENTIFIC TRADERS L5 | Chemi Health Diagnostic L10 | KALPATRU SCIENTIFIC L2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | Inj Dextrose 10% | 1 | No | 28.06 ₹28.06 | 39.9 ₹39.9 | - | - | - | 33.6 ₹33.6 | - | 25 ₹25 Lowest | - | - | - |
| 2.00 | Inj Dextrose 25% | 1 | No | 18.9 ₹18.9 Lowest | 20.19 ₹20.19 | - | - | - | 21.6 ₹21.6 | - | 32 ₹32 | - | - | - |
| 3.00 | Inj Dextrose 5% | 1 | No | - | 19.99 ₹19.99 Lowest | - | 19.99 ₹19.99 Lowest | - | 25 ₹25 | - | 21 ₹21 | - | - | - |
| 4.00 | Inj Methergine | 1 | Amp | - | 8.55 ₹8.55 | - | - | - | 14.4 ₹14.4 | - | - | - | 7.98 ₹7.98 Lowest | - |
| 5.00 | Inj Sodium Thioenen | 1 | Amp | - | 46.4 ₹46.4 Lowest | - | - | - | 57.6 ₹57.6 | - | - | - | - | - |
| 6.00 | Inj Drotine | 1 | Amp | 4.25 ₹4.25 Lowest | 4.29 ₹4.29 | - | - | - | 7.2 ₹7.2 | - | - | - | 5.5 ₹5.5 | - |
| 7.00 | Inj Epidosin | 1 | Amp | - | 8.39 ₹8.39 | - | - | - | 40.8 ₹40.8 | - | 11 ₹11 | - | 4.9 ₹4.9 Lowest | - |
| 8.00 | Inj Haemoxil | 1 | Amp | - | 445 ₹445 Lowest | - | - | - | 499 ₹499 | - | 450 ₹450 | - | 489 ₹489 | - |
| 9.00 | Inj Isolite P | 1 | No. | 25.5 ₹25.5 Lowest | 29 ₹29 | - | - | - | 42 ₹42 | - | - | - | - | - |
| 10.00 | Inj Anti-D 300mg | 1 | Vail | - | 3,959 ₹3,959 | - | - | - | 4,070 ₹4,070 | - | 2,900 ₹2,900 Lowest | - | 4,298 ₹4,298 | - |
Tender Value
₹3.5 L
EMD Value
₹5,000
Closing Date
13 Jun 2026, 4:00 pmClosed
BLOCK MEDICAL OFFICER SHANGUS
SDH Shangus
Provision of Drugs Diagnostic Items Consumables and Hospital Equipments
2026_HME_311697_1
05/NIT/2067-27/BMO
Open Tender
Medicines
Item Rate
SDH SHANGUS
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹5,000
1 Jul 2026
8 Jun 2026
15 Jun 2026
8 Jun 2026
13 Jun 2026
8 Jun 2026
8 Jun 2026 - 13 Jun 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Inj Dextrose 10% | - | No | - | - |
| 2 | Inj Dextrose 25% | - | No | - | - |
| 3 | Inj Dextrose 5% | - | No | - | - |
| 4 | Inj Methergine | - | Amp | - | - |
| 5 | Inj Sodium Thioenen | - | Amp | - | - |
| 6 | Inj Drotine | - | Amp | - | - |
| 7 | Inj Epidosin | - | Amp | - | - |
| 8 | Inj Haemoxil | - | Amp | - | - |
| 9 | Inj Isolite P | - | No. | - | - |
| 10 | Inj Anti-D 300mg | - | Vail | - | - |
stage.html
html • 0.08 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 3.16 MB
NITJune2026new.pdf
Tender Documents • 3.15 MB
BOQ_1009190.xls
BOQ • 0.53 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .